1. Home
  2. OPHC vs RFL Comparison

OPHC vs RFL Comparison

Compare OPHC & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimumBank Holdings Inc.

OPHC

OptimumBank Holdings Inc.

HOLD

Current Price

$4.33

Market Cap

47.3M

Sector

Finance

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.46

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPHC
RFL
Founded
2000
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
47.3M
54.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OPHC
RFL
Price
$4.33
$1.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
38.9K
143.0K
Earning Date
11-10-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
89.25
N/A
EPS
1.30
N/A
Revenue
$43,818,000.00
$1,029,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.34
N/A
Revenue Growth
26.98
47.63
52 Week Low
$3.53
$1.17
52 Week High
$5.04
$3.19

Technical Indicators

Market Signals
Indicator
OPHC
RFL
Relative Strength Index (RSI) 67.42 64.11
Support Level $4.11 $1.21
Resistance Level $4.25 $1.60
Average True Range (ATR) 0.07 0.08
MACD 0.02 0.04
Stochastic Oscillator 96.44 67.44

Price Performance

Historical Comparison
OPHC
RFL

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: